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Abstract
RhoGTPases play important roles in the regulation of protein transport and membrane recycling. 
Little is known, however, about how RhoGTPases affect HIV-1 virion production, which is 
dependent on the endosomal sorting pathway. We report that ectopic expression of citron kinase 
(citron-K), a RhoA effector, preferentially enhances HIV-1 virion production. Depletion of 
endogenous citron-K inhibits HIV-1 virion production. Citron-N, which lacks the kinase domain, 
also enhances HIV-1 virion production. The leucine zipper, Rho-binding and zinc finger domains 
of citron-N are necessary for the enhancement activity. Citron-K also enhances murine leukemia 
virion production and the HIV-1 late domain is not required for the citron-K-mediated 
enhancement. Ectopic expression of citron-K leads to the formation of cytoplasmic structures 
containing citron-K and HIV-1 Gag proteins. HIV-1 and citron-K cooperatively enhance acidic 
endosome and lysosome compartments. Finally, citron-K promotes exocytosis of microvesicles or 
exosomes that co-purify with HIV-1 virions. We conclude that citron-K enhances HIV-1 virion 
production by stimulating the endosomal compartments and exocytosis.
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HIV-1 replication is modulated by a number of cellular signaling pathways regulated by 
both host and viral factors (1). HIV-1 assembly and release occur in a series of essential 
steps mediated by the viral Gag precursor protein, Pr55Gag (2,3). HIV-1 Gag is organized 
into four distinct regions: matrix, capsid, nucleocapsid and late (L) domain. The L domain 
catalyzes the pinching off and detachment of virus particles from the cell surface and each 
other (2). The L domain is a highly conserved Pro-rich motif found in enveloped viruses. 
There are three classes of tetrapeptide motifs: PT/SAP (4,5), PPXY (6–8) and YPXL (9). In 
the case of HIV-1, the L domain is encoded by a small peptide motif, Pro-Thr/Ser-Ala-Pro 
(PTAP) in the C-terminal, p6 domain of Pr55Gag. The L domains of retroviruses, despite 
differences in amino acid sequence and location within their respective viral structural 
proteins, are functionally interchangeable, suggesting commonality of function, perhaps as 
docking sites for host proteins (10–12). Mutations in the PTAP motif of p6 or deletion of the 
p6 domain produced a striking defect in the production of virus particles where viral 
particles remain tethered to each other and the plasma membrane (4,5), thereby identifying 
the p6 domain as playing a critical role in HIV-1 budding.
Viruses like HIV-1 do not encode their own machinery for viral budding and must usurp 
existing cellular pathways to facilitate viral release. The PTAP motif of HIV-1 Gagp6 was 
found to bind to the ubiquitin enzyme 2 variant domain of Tsg101 (13–16). Tsg101 is a 
component of the endosomal sorting complex required for transport (ESCRT-I), a 350 kDa 
cellular complex essential in the vacuolar protein-sorting (VPS) pathway. Point mutations in 
HIV-1 PTAP motif block virus release at late stages (4,5) and disrupt binding to Tsg101 
(14). Small inhibitory RNA-mediated Tsg101 depletion potently blocks HIV-1 release 
resulting in the virus forming stalks of tethered virus at the plasma membrane (14). 
Moreover, overexpression of the dominant-negative form of VPS4, an ESCRT recycling 
factor, inhibits particle release of HIV-1 and other enveloped viruses, such as murine 
leukemia virus (MLV) (14). Moreover, a second region of HIV-1 Gagp6 has been defined to 
contribute to viral release and interacts with AIP1, a host protein (17,18). AIP1 interacts 
with Tsg101 and CHMP proteins of ESCRT-III complex, coupling HIV-1 Gagp6 to the early 
and late-acting endosomal sorting complexes and binds directly to HIV-1 Gagp6 Leu-Arg-
Ser-Leu (LRSL) motif (17,18). Taken together, these data suggest that the VPS machinery 
and perhaps other host factors are involved in facilitating the budding of retroviruses.
The endosomal sorting pathway controls a variety of cellular processes and plays a role in 
the sorting of ubiquitinated cargo proteins into the lumen of the multi-vesicular bodies 
(MVB) (19,20). Ubiquitinated proteins are recognized on the limiting endosomal membrane 
and sorted resulting in either MVB fusion with the lysosome to degrade contents or release 
of material into the extra-cellular environment via exosomal vesicles (21–23). ESCRT-I, 
composed of Tsg101, Vps28 and Vps37, recognize the ubiquitinated protein cargo and 
recruit two more class E protein cargos (ESCRT-II/III) that participate in protein sorting and 
vesicle formation (24–26). HIV-1 may bind Tsg101 and AIP1 to gain access to downstream 
machinery involved in catalyzing MVB vesicle budding, a mechanism topologically similar 
to viral budding from the plasma membrane.
RhoGTPases play a pivotal role in the dynamic regulation of actin cytoskeleton (27–29) and 
through this, control cell morphology (30,31), motility, adhesion and activation of 
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transcription factors such as NF-κB (32) and serum response factor (33). Although 
RhoGTPases have been implicated in various steps of T-cell activation (34–36), little is 
known about how RhoGTPases affect HIV-1 replication. We have previously shown that the 
cytoplasmic tail of the HIV-1 transmembrane glycoprotein interacts with the carboxy-
terminus of p115RhoGEF (37), a guanine nucleotide exchange factor and activator of RhoA. 
Activation of RhoA by p115RhoGEF or Gα13 leads to inhibition of HIV-1 gene expression 
in a RhoA-dependent manner (38). The RhoA effectors involved in modulating HIV-1 gene 
expression are not defined.
To investigate how RhoA-signaling pathways modulate HIV-1 replication, we tested various 
RhoA effectors in 293T and human T cells. We determined that citron kinase (citron-K), a 
Ser/Thr kinase, enhances HIV-1 virion production with no significant effect on HIV-1 gene 
expression. Knockdown of citron-K by short-hairpin RNA (shRNA) reduced HIV-1 virion 
production but not HIV-1 gene expression. Citron-K also enhanced MLV production, as well 
as virion production from a HIV-1 GagΔp6 construct, suggesting that citron-K mediates 
virion production independently of the HIV-1 L domain. Citron-K induced intra-cellular 
compartments and colocalized with Gag in these compartments. HIV-1 and citron-K 
cooperatively enhanced acidic (late) endosome and lysosome compartments. Furthermore, 
citron-K enhanced exocytosis of microvesicles or exosomes that co-purify with HIV-1 
virions.
Results
Citron-K preferentially enhances HIV-1 viral replication
To investigate how RhoA-signaling pathways modulate viral replication, we tested various 
RhoA effectors for their effect on HIV-1 viral replication in 293T and human T cells. 
Ectopic expression of citron-K, a RhoA effector involved in cytokinesis (39) and membrane 
vesicle transport (40–42), was shown to preferentially enhance HIV-1 virion production 
without significantly affecting HIV-1 gene expression in 293T (Figure 1A–D), Jurkat T 
(Figure 1E–G) and HeLa cells (data not shown). Both infectious virions (Figure 1A, E) and 
total virions (virion-associated RT activity or p24; Figure 1B and data not shown) 
demonstrated a similar enhancement (7- to 15-fold), while expression of HIV-1 reporter 
gene (Figure 1C, F) and cell-associated viral proteins (Figure 1D, G) showed minimal 
enhancement (<2.5-fold in 293T cells and no change in Jurkat T cells). The C-terminal 
truncation mutant of citron-K, citronΔ1, did not enhance HIV-1 virion production. We 
conclude that citron-K preferentially enhances HIV-1 virion production with minimal effect 
on HIV-1 gene expression and that activity depends on the C-terminal domains of citron-K.
To evaluate a role for endogenous citron-K in HIV-1 virion production, we depleted 
endogenous citron-K from 293T and Jurkat T cells using shRNA constructs that targeted 
various regions of citron-K (Figure S1). The 293T cells were transfected twice, first with 
control or citron-targeted shRNA constructs only and 24 h later, cells were co-transfected 
with citron-targeted shRNA constructs and pNL4GFP. Supernatant and cells were harvested 
48 h after the second transfection and analyzed. We saw efficient knockdown of citron-K 
protein (65–90%; Figure 2A) and a 75–85% reduction in virion production by all three 
constructs as determined by p24 enzyme-linked immunosorbent assay (Figure 2B). HIV-1 
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gene expression, as measured by cell-associated Gag, was not affected by depletion of 
citron-K (Figure 2A). Jurkat T cells were also co-transfected with pNL4GFP and the citron-
specific shRNA or control constructs. Supernatants and cells were collected 48 h post-
transfection. Virion production was inhibited by 60% in citron-K-depleted cells compared 
with the control (Figure 2C). The inhibition of viral particle release correlated with 
reduction in expression of endogenous citron-K (Figure 2D). Therefore, citron-K is required 
for efficient HIV-1 virion production.
The leucine zipper, Rho-binding and zinc finger domains, but not kinase activity, of citron-
K are necessary for enhancing HIV-1 virion production
Deletion mutants were generated to map the domain(s) of citron-K involved in the 
enhancement of HIV-1 virion production. Citron-N, a naturally occurring splice variant of 
citron-K lacking the N-terminal kinase domain, showed similar enhancement activity as 
citron-K, indicating that the kinase domain was dispensable (Figure 3A). Next, we made a 
series of C-terminal truncation mutants in the citron-N gene. The PH, SH3 and PDZ 
domains were not required for the activity. The zinc finger motif of citron was necessary for 
the enhancement of virion production because deletion of the zinc finger domain from 
citron-N (CNΔZnF) abolished its ability to enhance virion production (Figure 3A). The zinc 
finger domain alone was unable to enhance virion production (Figure 3A). Further deletion 
of the N-terminal α-helix demonstrated that two copies of the leucine zipper motif and the 
Rho-binding domain (RBD), in addition to the zinc finger, were sufficient for citron-
mediated viral
Citron-K enhances release of MLV and of HIV-1 Gag lacking the L domain
The L domain is important for retroviral release (4,5). HIV-1 viral release is dependent on 
the unique HIV-1 L domain to interact with the endosomal sorting protein Tsg101 and 
subsequently the endosomal sorting pathway (14). Release of MLV, which contains a 
different L domain tetrapeptide sequence (PPPY) than HIV-1 (PTAP), is unaffected by 
depletion of Tsg101. To determine if citron-K enhancement of virion production is HIV-1 
specific, we evaluated whether citron-K was able to enhance MLV production. Citron-K 
enhanced MLV virion production to comparable levels as HIV-1 (Figure 4A), suggesting 
that citron-K has a general enhancement activity on retroviral production.
To further determine the role of HIV-1 L domain in citron-K-mediated virion production, 
we transfected 293T cells with Gag or GagΔp6 constructs (43). The GagΔp6 construct, 
which lacks the entire L domain, showed significantly reduced virion production compared 
to full-length Gag (Figure 4B). Citron-K enhanced virus-like particle (VLP) production 
similarly from HIV-1 Gag proteins with or without the L domain (5–7 fold; Figure 4B, C). 
These results demonstrate that citron-K enhances HIV-1 virion production independent of 
the viral L domain.
Citron-K induces formation of intracellular compartments and co-localizes with HIV-1 Gag
To define a possible mechanism by which citron-K enhances HIV-1 virion production, we 
evaluated the subcellular localization of citron-K and HIV-1 Gag in 293T cells by confocal 
microscopy. Citron-K localized to unique compartments that accumulated in the cytoplasm 
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[data not shown, previously described in (44)]. When GagGFP was expressed alone or 
GagGFP and Gag were co-expressed in 293T cells (Figure 5A, C), Gag exhibited 
cytoplasmic and plasma membrane localization, the primary site for HIV-1 release. 
However, when GagGFP or GagGFP/Gag were co-expressed with citron-K, Gag localized 
to the same dense protein compartments that expressed citron-K (Figure 5B, D). Citron-K 
mediated relocalization of Gag to these citron-K-induced intracellular structures may 
mediate enhancement of virion production.
Citron-K enhances HIV-1 virion production by modulating late endosomal compartments 
and exocytosis
Next, we determined the effect of citron-K on the late endosomal and lysosomal 
compartments during HIV-1 replication because all retroviruses are dependent on the late 
endosomal sorting pathway for virion release. Cells were co-transfected with citron-K 
and/or HIV-1 proviral DNA (pNL4-3) and labeled with LysoTracker, a dye that marks 
acidic endosomal/lysomal compartments (i.e. low internal pH). Citron-K or HIV-1 alone 
showed no significant effect on these compartments (Figure 6A–C). Citron-K and HIV-1, 
however, cooperatively enhanced the acidic late endosomal and lysosomal compartments 
(Figure 6D). The results from confocal microscopy were supported by fluorescence-
activated cell sorter (FACS) analysis of the LysoTracker signal (Figure 6E). These findings 
suggest that citron-K interacts with HIV-1 to enhance activity of the late endosomal sorting 
pathway to promote HIV-1 virion production.
In the endosomal sorting pathway, the MVB either fuses with the lysosome to degrade its 
contents or is directed to the plasma membrane where its contents are released via an 
exocytic pathway. Interestingly, HIV-1 virions have been shown to resemble exosomes (or 
exocytosed microvesicles) in both size and components (45–48). We hypothesized that 
citron-K modulates the exocytic pathway to promote HIV-1 virion production as well as 
MVB exocytosis. To test this, we purified microvesicles or exosomes secreted from cells 
transfected with HIV-1 proviral DNA in the presence and absence of citron-K. Our results 
indicate that citron-K enhanced the secretion of microvesicles with exosomal markers (i.e. 
hsc70, CD82 and LAMP-1), as well as HIV-1 virions, in HeLa (Figure 7A) and 293T cells 
(Figure 7C). The intracellular exosomal markers in the presence of citron-K and/or HIV-1 
were not significantly altered (Figure 7B, D). We conclude that citron-K enhances HIV-1 
virion production by promoting exocytosis of microvesicles/exosomes, including HIV-1 
virions.
Discussion
We investigated the role of citron-K, a RhoA effector, in modulating HIV-1 replication. 
Ectopic expression of citron-K and the kinase-deficient splice variant citron-N preferentially 
enhanced HIV-1 virion production but not HIV-1 gene expression. Knockdown of 
endogenous citron-K by shRNA inhibited HIV-1 virion production, demonstrating an 
important role for endogenous citron-K in viral budding. Citron-K also enhanced MLV 
production and the HIV-1 L domain was not required for the enhancement. Citron-K forms 
cytoplasmic structures (44) and, when both HIV-1 Gag and citron-K are co-expressed, Gag 
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is colocalized to these citron-K-induced cytoplasmic structures. Further analysis of the 
endosomal sorting pathway indicated that citron-K, together with HIV-1, enhanced the 
compartments of acidic late endosomes and lysosomes. We demonstrated that production of 
microvesicles or exosomes and HIV-1 virions were both enhanced by citron-K. These 
results suggest that citron-K is involved in modulating exocytosis and HIV-1 virion 
production.
RhoGTPases play a central role in the dynamic regulation of the actin cytoskeleton and 
through this, control cell morphology, motility and adhesion (49,50). RhoGTPases act 
locally to control individual trafficking events, but also act globally to control the spatial 
organization of membrane traffic in response to cues from the extracellular environment. In 
addition to interacting with the endocytic pathway to modulate clathrin-independent 
internalization from the cell surface (51,52), RhoGTPases are involved in mediating 
trafficking/sorting decisions at a number of distinct endocytic subcompartments. For 
example, RhoD is localized to both the plasma membrane and early endocytic vesicles, 
resulting in activation of an isoform of Diaphanous and tyrosine kinase c-Src (53). RhoB, 
which is highly homologous to RhoA, is localized to the plasma membrane and the 
bounding membrane of MVBs (54,55) and is activated by internalized epidermal growth 
factor receptors, as they enter the late endosomal compartment (56). These findings suggest 
that RhoGTPases interface the actin cytoskeleton with endocytic trafficking events. 
Activated RhoA mediates a number of effectors that modulate distinct cellular processes. 
For example, an undefined RhoA effector inhibits HIV-1 gene expression (38), making it 
difficult to evaluate the effect of activating citron-K specifically via RhoA on HIV-1 virion 
budding or production.
There are two endogenous forms of citron, the kinase form (citron-K) and the non-kinase 
form (citron-N). Citron-K is ubiquitously expressed in most cell types with cell cycle-
dependent cellular localization (57). RhoA co-localizes with citron-K in the cell cortex 
during anaphase and both are enriched in the cleavage furrow and midbody during telophase 
(39). Citron-K modulates the contractile motion required for separation of the two daughter 
cells during cytokinesis through phosphorylation of the regulatory light chain of myosin II at 
both Ser-19 and Thr-18 (58). It is feasible that citron-K enhances virion budding from host 
cells in a similar process as cytokinesis. However, our observation that the kinase domain is 
not required to enhance HIV-1 virion production indicates that a distinct mechanism is 
involved.
Citron-N is a splice variant of citron-K lacking the kinase domain (59). Actin 
polymerization and cytoskeleton are regulated by RhoGTPases and are essential for the 
organization and dynamics of membrane organelles such as endosomes and the Golgi 
complex (40–42). Citron-N is enriched and associated with the Golgi apparatus of 
hippocampal neurons in culture (60). Suppression of citron-N or expression of a mutant 
lacking Rho-binding activity leads to dispersion of the Golgi apparatus (60), suggesting that 
citron-N functions as a scaffolding molecule on Golgi membranes, organizing Rho-mediated 
actin polymerization locally by assembling the actin polymerizing complexes together 
(ROCK II and profilin-IIa) (60). Citron-N also interacts with the postsynaptic scaffold 
protein, PSD-95/SAP-90, a member of the membrane-associated guanylate kinase protein 
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family (MAGUK) (61,62). This interaction is important for neural plasticity and its 
localization at postsynaptic sites in all hippocampal neurons (61,62). Therefore, citron-N 
may play a role in organization of the endosomal sorting pathway and regulation of the actin 
cytoskeleton to facilitate exocytosis and viral release. However, neither monomeric nor 
polymerized actin appears to be altered by citron-K and/or HIV-1 in transfected 293T or 
HeLa cells (R. Loomis and L. Su, UNC-CH, Chapel Hill, NC, unpublished data).
We determined that the region of citron-K necessary for enhancement of virion production 
contained the leucine zipper, the RBD and the zinc finger domains. It has been speculated 
that the leucine zipper domain may be a scaffold for multimeric structures functioning 
through conformational changes and interactions with additional partners (59). The zinc 
finger (C6H2) in citron-K is believed to bind lipid second messengers or to recruit additional 
proteins (59). Taken together, citron-K may enhance virion production by binding or 
recruiting other cellular (perhaps endosomal sorting proteins) or viral components to 
facilitate viral release.
Recent evidence has shown that Tsg101, a component of ESCRT-I, binds specifically to the 
L domain of HIV-1 Gag to promote viral release (13–15). Small inhibitory RNA-mediated 
depletion of Tsg101 potently blocked HIV-1 release but not MLV release (14). We showed 
that citron-K enhanced virion production of MLV. Citron-K also enhanced VLP production 
of HIV-1 GagΔp6, which lacks the L domain. Therefore, this citron activity probably affects 
a step of HIV-1 viral release that is distinct from the Tsg101-dependent step. Dominant-
negative mutants of Vps4 inhibited viral release of both HIV-1 and MLV, indicating the 
essential role of the late endosomal pathway in mediating retroviral release (14). Co-
expression of dominant-negative Vps4 mutants also blocked HIV-1 virion production in the 
absence or presence of citron-K (R. Loomis and L. Su, UNC-CH, Chapel Hill, NC, 
unpublished data). Therefore, citron-K enhanced virion production is still dependent on the 
late endosomal sorting pathway.
HIV-1 can bud from both the plasma membrane and internal endosomal membranes 
(14,18,43,63–67). Citron-K may either recruit late endosomal factors to the plasma 
membrane or promote utilization of the endosomal pathway for virion production. Cells 
transfected with both citron-K and HIV-1 lead to increased late endosome and lysosome 
compartments compared to cells transfected with HIV-1 or citron-K alone. Based on the 
localization of citron-K and colocalization of Gag, it is likely that citron-K promotes a step 
late in the endosomal sorting pathway to enhance virion production. HIV-1 virions share 
similar characteristics with exocytosed membrane microvesicles or exosomes (66,68). They 
are similar in size and contain exosome-specific markers, as well as common cellular 
membrane proteins. Although exosome production occurs more prominently in 
macrophages, B cells and dendritic cells, recent evidence indicates that the exosomal 
pathway operates in most blood cell types, including T cells (69). Our data suggest that 
citron-K is involved in modulating the exocytosis process to enhance HIV-1 virion 
production. In addition, HIV-1 may interact functionally with citron-K to modulate 
endosomal sorting and HIV-1 virion release.
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Remarkably, citron-K−/− mice are viable, although they grow at slower rates, are severely 
ataxic and die before adulthood as a consequence of fatal seizures (70). Since knockdown of 
endogenous citron-K expression in 293T and T cells inhibited HIV-1 virion production, 
citron-K may provide a new host target for the development of anti-HIV-1 therapeutics. In 
addition to affecting HIV-1 viral production, the altered release of exosomes/microvesicles 
may also have significant immunological consequences, as exosomes have been shown to 
function as antigen-presenting cells to interact with T cells (66,68,69,71).
Materials and Methods
Reagents, plasmids and cell lines
The pNL4-3 plasmid encodes the entire HIV-1 genome DNA in pUC18 (24). The 
pNL4.Luc.R-E plasmid was obtained from the National Institutes of Health (NIH) AIDS 
Research and Reference Reagent Program (72). The pNL4GFP plasmid encodes Gag, Pol, 
tat and rev and was kindly provided by Dr Dan Littman, NYU, NY, NY. pCAG (vector), 
pCAG/citron-K, pCAG/citronΔ1 plasmids were previously reported (57). All citron 
truncation mutants were generated by polymerase chain reaction of the citron-N template 
with an N-terminal Myc-tag added and inserted into a retroviral vector, pHSCG (73). The 
control (pSUPER.Retro.Puro; OligoEngine, Seattle, WA, USA) and citron short-hairpin 
constructs (cit A, cit B and cit C) were a kind gift from Dr Alan Hall, University College 
London, London, UK. Gag and GagΔp6 constructs were a kind gift from Dr Paul Bieniasz, 
Aaron Diamond AIDS Research Center, NY, NY (43) and GagGFP was a kind gift from Dr 
Marilyn Resh, Sloan-Kettering Institute, NY, NY.
The 293T, HeLa and HeLa-MAGI cells [NIH AIDS Research and Reference Reagent 
Program; (73)] were maintained in DMEM supplemented with 10% FBS, penicillin/
streptomycin and L-glutamine. Jurkat T cells were maintained in RPMI-1640 supplemented 
with 10% FBS, penicillin/streptomycin and L-glutamine. The NIH-3T3 cells were 
maintained in DMEM supplemented with 10% FBS, penicillin/streptomycin and L-
glutamine.
HIV-1 production and replication in transfected human cells
Transient production of HIV-1 was performed by transfecting NL4-3 (0.1 μg) with pCAG, 
pCAG/citron-K, pCAG/citronΔ1 or citron truncation plasmids (0.2 μg) in 293T cells in 48-
well plates at 2.5 × 104 cells/well using Effectene (Qiagen, Santa Clarita, CA, USA) or 
NL4-3 (0.3 μg) with pCAG, pCAG/citron-K, pCAG/citronΔ1 or citron truncation plasmids 
(0.6 μg) in Jurkat T cells in 48-well plates at 4 × 105 cells/well using GenePorter (Gene 
Therapy Systems, San Diego, CA, USA). At 48 h post-transfection, HIV-1 virions in cell 
supernatant were measured by p24 or RT assays (74) and infectious units were determined 
by titering the supernatant on HeLa-CD4-LTR-lacZ cells (MAGI) as described previously 
(73).
To analyze HIV-1 gene expression in transfected cells, pNL4.Luc (0.1 μg) was co-
transfected into 2.5 × 104 293T cells/well together with pCAG, pCAG/citron-K, pCAG/
citronΔ1 or citron truncation plasmids (0.2 μg) or pNL4.Luc (0.3 μg) was co-transfected into 
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4 × 105 Jurkat T cells/well with pCAG, pCAG/citron-K, pCAG/citronΔ1 or citron truncation 
plasmids (0.6 μg). Cell extracts were analyzed at 48 h after transfection for luciferase 
activity (EG&G berthold, Oak Ridge, TN and FluoStar Optima; BMG LabTech, Durham, 
NC). In some experiments, we used pGag, pGagΔp6 or pNL4GFP, in place of NL4-3 or 
pNL4.Luc.
Western blotting
Transfected 293T or Jurkat T cells were lysed and resolved (50–100 μg of total protein) on a 
10% SDS–PAGE. Gels were transferred to polyvinylidene fluoride (PVDF) membranes 
(Amersham Biosciences, Piscataway, NJ) and blocked with 5% non-fat dry milk. The 
membrane was probed with mouse anti-p24 (NIH AIDS Research and Reference Reagent 
Program), mouse anti-Myc (AbCam, Cambridge, MA, USA), rabbit anti-citron [a kind gift 
from Dr Lola Reid, UNC-CH, as described in (75)], mouse anti-actin (Sigma-Aldrich, St 
Louis, MO), mouse anti-tubulin, mouse anti-hsc70 (BD Biosciences, San Jose, CA), mouse 
anti-LAMP1 (Santa Cruz, Santa Cruz, CA) or mouse anti-CD82 (BD Biosciences, San Jose, 
CA) specific antibodies and visualized using an enhanced chemiluminescence Kit 
(Amersham Biosciences, Piscataway, NJ).
shRNA knockdown of citron-K
The citron-K shRNA and control constructs are in the pSUPER.Retro.Puro vector from 
OligoEngine. The citron-K shRNA constructs target different regions of citron-K. Cit A 
RNA targets the C-terminus of citron-K beginning at base pair 6085, Cit B and Cit C RNA 
target the N-terminus of citron-K beginning at base pair 359 and 244, respectively, (Figure 
S1). For experiments in 293T cells, 293T cells were plated in a 24-well plate at 5 × 104 
cells/well and transfected with 0.4 μg control or citron-targeted shRNA constructs using 
Effectene. Twenty-four hours later, another transfection was performed with 0.1 μg 
pNL4GFP and 0.2 μg control or citron-targeted shRNA constructs. Two days after the 
second transfection, supernatants and cells were harvested for further analysis. For 
experiments in Jurkat T cells, 0.3 μg of pNL4GFP and 0.6 μg of control or citron-targeted 
shRNA constructs were transfected via GenePorter into 4 × 105 cells/well. Supernatants and 
cells were harvested at 48 h post-transfection for further analysis.
MLV production in transfected human cells
The 293T cells were plated in a 6-well plate at 4 × 105 cells/well and transfected with 2 μg 
HSCG (a retroviral vector with MSCV LTR, 34), 1.5 μg vesicular stomatitis virus-
glycoprotein (VSV-G), 1.5 μg murine leukemia virus (MLV) Gag-Pol and 2 μg vector or 
citron-K DNA using the calcium phosphate transfection method as described previously 
(76,77). Retrovirus was harvested 48 h after transfection. Virus was titered by seeding 
NIH-3T3 cells at 5 × 104 cells/well in a 24-well plate, adding serial dilution of virus and 
counting GFP-positive cells 48 h after infection on the Guava EasyCyte (Guava 
Technologies, Hayward, CA).
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The 293T cells were plated on coverslips at 1 × 105 cells/well in a 24-well plate and 
transfected as described previously (Effectene, Qiagen). For the GagGFP confocal 
experiments, we used 0.2 μg of GagGFP, 0.02 μg vector, 0.4 μg vector or citron-K and for 
the samples with wild-type Gag – 0.2 μg of GagGFP, 0.02 μg of Gag and 0.4 μg vector or 
citron-K were used in the transfections. At 48 h post-transfection, cells were fixed with 4% 
paraformaldehyde for 15 min at 4°C, washed once with cold 1×PBS, permeabilized with 
ice-cold methanol for 30 seconds, washed once with cold 1×PBS, washed three times with 
Quench Buffer (1% milk, 150 mM NaOAc pH 7, 1×PBS), washed three times with wash 
buffer (1% milk, 1×PBS), incubated with primary antibody for 1 h at room temperature, 
washed three times with wash buffer, incubated with secondary antibody for 1 h at room 
temperature, washed five times with wash buffer and mounted on slide with polyvinyl 
alcohol. The primary antibody used was chicken anti-Myc (Molecular Probes, Carlsbad, 
CA) at 1:1000 dilution. The secondary antibody used was anti-chicken-Cy5 (Molecular 
Probes, Carlsbad, CA) at 1:200 dilution.
For LysoTracker experiment, cells were incubated with 60 μM LysoTracker (Molecular 
Probes, Carlsbad, CA) for 90 min then fixed with 4% paraformaldehyde 48 h post-
transfection. Images were collected using Olympus confocal microscope and software.
FACS
Each sample (~5 × 105 cells) that had been incubated with 60 μM LysoTracker (Molecular 
Probes, Carlsbad, CA) for 90 min were washed in PBS with 2% FBS and stained with 
7AAD (1 μL/mL) for 15 min on ice, then rinsed and resuspended in PBS with 2% FBS. 
Cells were analyzed using FACScan (Becton Dickinson, San Jose, CA).
Purification of exosomal/microvesicles/HIV-1 virions
Transfections were performed as described previously (Effectene, Qiagen), except in 100-
mm dishes using 1 × 106 cells/plate of 293T cells or 5 × 105 cells/plate of HeLa cells. The 
FBS used to culture the cells was depleted of exosomes or microvesicles by spinning at 100 
000 × g overnight at 4°C. Supernatant (10 mL) were collected at 48 h post-transfection. The 
exosome purification protocol is similar to those described previously (66,71). At the time of 
collection, supernatants were spun at 800 × g for 10 min to remove cells and large cell 
debris. Supernatants were then added to Beckman Ultra Clear Centrifuges (11 × 89 mm) 
with 2 mL 25% sucrose. Tubes were spun in the Beckman L7 Ultracentrifuge at 100 000 × g 
for 2 h at 4°C. Supernatant was discarded and exosomal pellet was resuspended in 1% 
Triton-X-100 and analyzed by SDS–PAGE.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Citron-K preferentially enhances HIV-1 virion production
(A and B) 293T cells were co-transfected with proviral DNA NL4-3 and vector, citron-K or 
citronΔ1. Supernatant was harvested at 48 h post-transfection to determine infectious 
units/mL (A) or virion-associated RT activity (B). (C and D) 293T cells were co-transfected 
with pNL4.Luc and vector, citron-K or citronΔ1. Cells were harvested at 48 h post-
transfection to determine luciferase activity (C). (D) Cell-associated viral Gag proteins, 
Myc-tagged citron-K and actin in 293T cells were analyzed using anti-p24, anti-Myc and 
anti-actin antibodies, respectively. (E and F) Jurkat T cells were co-transfected with pNL4-3 
(E) or pNL4.Luc (F) and vector, citron-K or citronΔ1. Supernatants and cells were harvested 
at 48 h post-transfection to determine infectious units/mL (E) or luciferase activity (F). (G) 
Cell-associated viral Gag proteins (p55) and actin in Jurkat T cells were analyzed using anti-
p24 and anti-actin antibodies. Error bars are standard deviation of duplicate samples and at 
least three independent experiments were performed. *P < 0.05, **P < 0.005. enhancement 
(Figure 3). All citron truncation mutant proteins were efficiently expressed (Figure S2A, B).
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Figure 2. Depletion of endogenous citron-K inhibits HIV-1 virion production
(A and B) Knockdown of endogenous citron-K using citron-targeted shRNA constructs in 
293T cells inhibited HIV-1 virion production. 293T cells were transfected with citron-
targeted shRNA or control plasmid constructs, 24 h later, cells were co-transfected with 
pNL4GFP and citron-targeted shRNA or control plasmid constructs. Supernatant and cells 
were harvested 48 h after the second transfection and analyzed for cell-associated gene 
expression of citron-K, p24 and actin (A) and relative HIV-1 virion production in the 
supernatant (p24 pg/mL) (B). (C and D) Knockdown of endogenous citron-K in T cells 
inhibited HIV-1 virion production. Jurkat T cells were transfected with pNL4GFP and 
citron-targeted shRNA or control plasmid constructs. Supernatant and cells were harvested 
at 48 h post-transfection. The effect of citron-K knockdown on HIV-1 virion production in 
the supernatant was measured by p24 enzyme-linked immunosorbent assay (C). *P < 0.05. 
Cells were lysed and analyze with anti-citron and anti-actin antibodies (D).
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Figure 3. Leucine zipper, RBD and zinc finger motifs, but not the kinase domain, are necessary 
for citron-K to enhance HIV-1 viral release
(A) 293T cells were co-transfected with pNL4-3 and citron truncation constructs. 
Supernatants were harvested at 48 h for infectious unit assays. Graph depicts fold 
enhancement of infectious units by various citron truncation mutants compared with vector 
control. *P < 0.05. (B) Schematic diagram of the citron-K constructs and of results shown in 
(A). +, enhancement of viral release.
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Figure 4. Citron-K enhanced release of MLV and HIV-1 GagΔp6
(A) MLV virus-like particle production was similarly enhanced by citron-K. 293T cells were 
co-transfected with MLV Gag-Pol, VSV-G-env and HSCG (an MLV-based retroviral vector 
expressing GFP) with citron-K or control vector. Supernatant was collected at 48 h post-
transfection and titered for GFP expression on 3T3 cells to determine infectious units/mL. 
(B and C) Citron-K enhancement of virion production is L domain independent. 293T cells 
were co-transfected with Gag or GagΔp6 and vector or citron-K. Supernatant and cells were 
harvested 48 h post-transfection for analysis. (B) Citron-K enhances virion production of 
both HIV-1 Gag and GagΔp6. Virion production of GagΔp6 alone is significantly reduced 
compared with Gag but is enhanced by citron-K. (C) Citron-K similarly enhances virion 
production of HIV-1 Gag, GagΔp6 and NL4-3. Shown is relative enhancement of virion 
production of Gag, GagΔp6 and NL4-3 from two independent experiments. *P < 0.05, **P 
< 0.005.
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Figure 5. Citron-K and Gag colocalize to citron-K-induced cytoplasmic compartments
(A and C) 293T cells were transfected with GagGFP or GagGFP/Gag in a 10:1 ratio and 
protein localization was determined by confocal microscopy. GagGFP localizes primarily to 
the plasma membrane in the absence of exogenous citron-K. (B and D) 293T cells were co-
transfected with GagGFP or GagGFP/Gag combination and citron-K. The localization of 
GagGFP is altered in the presence of citron-K. Instead of localizing to the plasma 
membrane, GagGFP localized intracellularly with citron-K into ‘citron-induced cytoplasmic 
compartments’ (indicated by arrows). N; nucleus. Bars represent 17.5 μm.
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Figure 6. Citron-K and HIV-1 cooperatively enhance acidic (late) endosomal and lysosomal 
compartments
293T cells were transfected with pNL4-3 and vector or citron-K. Cells were incubated with 
60 μM LysoTracker for 90 min before fixation at ~48 h post-transfection. (A–D) Images of 
LysoTracker signals were collected via confocal microscopy. N, nucleus. Bars represent 7 
μm. (E) Relative LysoTracker signals of 293T cells were measured by FACS analysis 
(average of four independent experiments). **P < 0.005.
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Figure 7. Citron-K enhances exocytosis
(A and B) HeLa cells or (C and D) 293T cells were co-transfected with pNL4-3 and vector 
or citron-K. Supernatant and cells were collected 48 h post-transfection for analysis. The 
microvesicles and virion pellets in the supernatant were purified and analyzed for late 
endosomal/exosomal markers and HIV-1 Gag p24 (A and C). Exosomal markers analyzed 
include hsc70, LAMP-1 and CD82. Cell-associated proteins were analyzed for late 
endosomal/exosomal markers (B and D).
Loomis et al. Page 21
Traffic. Author manuscript; available in PMC 2015 May 05.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
